Henan Dingxin Pharmaceutical Technology Co., Ltd

Focusing on life sciences and caring for human health

General Office�/p>

0373-6351898

Monday to Saturday 8:00-17:00

Publicity information

TUOXIN

Products and Services

A high-tech enterprise that integrates the production and sales of chemical synthesis, fermentation of nucleoside series pharmaceutical intermediates, and nucleoside series raw materials

pharmaceutical intermediates

Chemical products used in the synthesis of chemical drugs. After nearly 20 years of development and accumulation, the company has formed multiple series of nucleoside (acid) products, including pyrimidine series, purine series, nucleotide series, and nucleoside series

Base series

Nucleoside series

Nucleotide series

Sugar series

Focusing on life sciences and caring for human health

Henan Dingxin Pharmaceutical Technology Co., Ltd

Henan Dingxin Pharmaceutical Technology Co., Ltd. was established in August 2022 with a registered capital of 125 million yuan. It is located at 2369 Muye Avenue (South), High tech Zone, Xinxiang City, Henan Province. It is a member enterprise controlled by Xinxiang Tuoxin Pharmaceutical Co., Ltd. (stock code 301089), a listed company on the Shenzhen Growth Enterprise Market. Its predecessor was Xinxiang Tuoxin Pharmaceutical Co., Ltd. Jingquan Branch, which integrates chemical synthesis A high-tech enterprise that integrates the production and sales of pharmaceutical intermediates and active pharmaceutical ingredients in the fermentation nucleoside series. It is one of the strong research and production bases for nucleoside and nucleotide drugs in China. The company covers an area of over 140 acres with a construction area of 34000 square meters, and currently has more than 600 employees.The company's main products include cytosine, 5F cytosine, cytidine, uracil, uridine, adenosine, etc. The company passed the "three standard integrated" system certification in December 2022, and its products are exported to more than 20 countries and regions such as the United States, Italy, Spain, Japan, India, and South Korea. The export of products is increasing day by day, and it has strong international competitiveness and market development capabilities.

Enterprise strength

A high-tech enterprise that integrates the production and sales of chemical synthesis, fermentation of nucleoside series pharmaceutical intermediates, and nucleoside series raw materials

Qualifications and honors

Relying on the strong corporate strength of the group company, Dingxin Pharmaceutical has passed the "Three Standards in One" system certification, HALAL certification, KOF-K Kosher certification, REACH registration, COSMOS certification, and has obtained multiple honorary certificates, possessing strong international competitiveness and market development capabilities.

production equipment

Dingxin Pharmaceuticals continuously improves its self requirements and production management level around quality, environmental protection, and safety. Currently, it has more than 100 sets of various research and development, production, processing, and inspection equipment, and continuously iterates various facilities according to market demand.

Scientific research strength

The company always focuses on "research and development innovation" and attaches great importance to investment in product research and development. Currently, multiple pharmaceutical intermediate products have passed certifications in countries and regions such as Japan and the European Union, such as the EU REACH registration certificate, HALAL halal certification, and KOSHER clean food certification.

Qualifications and honors

production equipment

Scientific research strength

News and information

A high-tech enterprise that integrates the production and sales of chemical synthesis, fermentation of nucleoside series pharmaceutical intermediates, and nucleoside series raw materials